NOVAVAX INC

NVAX Net selling

CIK 0001000694 #2303 in the set updated 18 Sep 2026

Bought (120 mo)

$1.47M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$166.65M

$0.00 on a plan · $145.77M straight out of an exercise

Sold at will

$20.89M

146 of 800 sales

Net

−$165.19M

−$19.42M against sales at will

By person

23 insiders · 848 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Erck Stanley C

President and CEO

$319.65K (3)

$47.96M (85) scheduled

−$47.64M

36,492

0.0221%

$291.94K

—

Glenn Gregory M

President, R&D

$135.19K (13)

$42.44M (348) scheduled

−$42.30M

18,339

0.0111%

$146.71K

—

Herrmann John A III

EVP, Chief Legal Officer

$5.56K (1)

$28.20M (164) scheduled

−$28.19M

16,617

0.0101%

$132.94K

—

Trizzino John

President and COO

$185.62K (3)

$26.34M (170) scheduled

−$26.15M

68,061

0.0413%

$544.49K

—

EVANS GARY C

Director

—

$6.85M (4) scheduled

−$6.85M

27,549

0.0167%

$220.39K

+11.4%

MOTT DAVID M

Director

—

$6.31M (5)

−$6.31M

79,770

0.0484%

$638.16K

+22.8%

YOUNG JAMES F

Director

$73.25K (1)

$5.60M (16) scheduled

−$5.53M

53,260

0.0323%

$426.08K

−80.7%

MCMANUS MICHAEL A JR

Director

$76.09K (3)

$2.07M (4) scheduled

−$1.99M

10,101

0.0061%

$80.81K

—

Dubovsky Filip

President, R&D

—

$858.80K (3) scheduled

−$858.80K

66,613

0.0404%

$532.90K

−5.6%

DOUGLAS RICHARD

Director

$357.79K (2)

—

+$357.79K

73,220

0.0444%

$585.76K

—

BOUDREAUX GAIL

Director

$144.85K (1)

—

+$144.85K

200,000

0.1213%

$1.60M

+100.0%

King Rachel K.

Director

$143.31K (4)

$37.44K (1)

+$105.88K

45,170

0.0274%

$361.36K

—

PHILLIPS BARCLAY A

SVP, Chief Financial Officer

$24.61K (3)

—

+$24.61K

38,669

0.0234%

$309.35K

+287.5%

Jacobs John C

President and CEO

—

—

—

225,680

0.1368%

$1.81M

—

O'Hara Elaine

EVP, Chief Strategy Officer

—

—

—

134,642

0.0816%

$1.08M

—

Kelly James Patrick

EVP, CFO and Treasurer

—

—

—

130,599

0.0792%

$1.04M

+5,143%

Casey Mark J

EVP, Chief Legal Officer

—

—

—

90,067

0.0546%

$720.54K

—

Alton Gregg H

Director

—

—

—

47,685

0.0289%

$381.48K

—

Rodgers Richard J

Director

—

—

—

47,370

0.0287%

$378.96K

—

MCGLYNN MARGARET G

Director

—

—

—

44,468

0.0270%

$355.74K

—

Draghia-Akli Ruxandra

EVP, Research & Development

—

—

—

23,563

0.0143%

$188.50K

—

Newton Charles W.

Director

—

—

—

9,520

0.0058%

$76.16K

—

Shiver John W.

Director

—

—

—

7,947

0.0048%

$63.58K

—

Individual transactions

0

Nothing of that kind in this period.

What was left out

Form 4 filings counted 361

Amendments (4/A) skipped 11

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 654

Sales at will 146

Transactions with no price 0

Shares from compensation/vesting 3,640,326

Sales filed before the plan box existed 140

History held since 21 Sep 2016